I'll be at
#CARTCR tomorrow speaking on our leading edge work
@PennMedicine Clinical Cell and Vaccine Production Facility. About us: we offer biotechnology companies, pharmaceutical partners, and academic investigators an integrated pathway for advancing cell and gene therapy programs from process development through first-in-human clinical trials.
Services include starting-material and cell processing, cell engineering, cGMP clinical manufacturing, lentiviral vector production and titration, process development and scale-up, platform evaluation, in-process and release testing, reagent qualification, master cell banks, and IND and early-phase clinical support.
We also provide extensive biomarker and correlative-study capabilities, including biobanking, multiparameter flow cytometry, qPCR/ddPCR, gene-expression and gene-editing assays, spatial biology, metabolomics, and off-target analysis.
With 15 ISO 7 processing suites, FACT accreditation since 2009, broad equipment expertise, and experience across oncology and immune diseases, CVPF provides a comprehensive bench-to-bedside infrastructure for partners seeking to translate complex living therapeutics efficiently and rigorously into the clinic.
med.upenn.edu/cvpf/iexternalβ¦